Search Results - "FALLET, Vincent"

Lung cancer is also a hereditary disease by Benusiglio, Patrick R, Fallet, Vincent, Sanchis-Borja, Mateo, Coulet, Florence, Cadranel, Jacques

“…Pathogenic genetic variants (formerly called mutations) present in the germline of some individuals are associated with a clinically relevant increased risk of…”
Get full text

Sarcomatoid lung carcinomas show high levels of Programmed Death Ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages by Vieira, Thibault, Antoine, Martine, Hamard, Cécile, Fallet, Vincent, Duruisseaux, Michael, Rabbe, Nathalie, Rodenas, Anita, Cadranel, Jacques, Wislez, Marie

“…Highlights • PD-L1, tumor-infiltrating lymphocytes (TIL) were higher in SC than in NSCLC. • High levels of TIL constituted a factor of good prognosis. • PD-L1…”
Get full text

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer by Cadranel, Jacques, Canellas, Anthony, Matton, Lise, Darrason, Marie, Parrot, Antoine, Naccache, Jean-Marc, Lavolé, Armelle, Ruppert, Anne-Marie, Fallet, Vincent

“…Immune checkpoint inhibitor-related pneumonitis (ICI-P) during cancer treatment is rarely observed (<5%). ICI-P is more often observed in patients with…”
Get full text

Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France by Calin, Ruxandra, Périllaud-Dubois, Claire, Marot, Stéphane, Kerrou, Khaldoun, Peytavin, Gilles, Bachir, Marwa, Kirch, Anne Laure, Lassel, Ludovic, Fallet, Vincent, Gozlan, Joel, Pain, Jean Baptiste, Senet, Patricia, Ferraris, Olivier, Bine, Sébastien, Hubert, Mathieu, Schwartz, Olivier, Morand-Joubert, Laurence, Pialoux, Gilles

“…We report a case of persistent disseminated mpox evolving over >6 months in an HIV/hepatitis B virus co-infected patient in France who had <200 CD4+ cells/mm ,…”
Get full text

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer by Sanchis-Borja, Mateo, Parrot, Antoine, Sroussi, Déborah, Rivin Del Campo, Eleonor, Fallet, Vincent, Cadranel, Jacques

Get more information

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports by Michaux, Lionel, Perrier, Alexandre, Mehlman, Camille, Alshehhi, Hussa, Dubois, Antonin, Lacave, Roger, Coulet, Florence, Cadranel, Jacques, Fallet, Vincent

“…ALK tyrosine kinase inhibitors (ALK TKIs) have improved prognosis in -rearranged ( ) non-small-cell lung cancer (NSCLC). However, drug resistance mechanisms…”
Get full text

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung by Vieira, Thibault, Antoine, Martine, Ruppert, Anne-Marie, Fallet, Vincent, Duruisseaux, Michael, Giroux Leprieur, Etienne, Poulot, Virginie, Rabbe, Nathalie, Sclick, Laurene, Beau-Faller, Michele, Lacave, Roger, Lavole, Armelle, Cadranel, Jacques, Wislez, Marie

“…Highlights • A dedifferentiation process in NSCLC could lead to sarcomatoid carcinoma (SC). • NSCLC and SC share morphological, immunohistochemical and…”
Get full text

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung by Saffroy, Raphaël, Fallet, Vincent, Girard, Nicolas, Mazieres, Julien, Sibilot, Denis Moro, Lantuejoul, Sylvie, Rouquette, Isabelle, Thivolet-Bejui, Françoise, Vieira, Thibaut, Antoine, Martine, Cadranel, Jacques, Lemoine, Antoinette, Wislez, Marie

“…MET exon 14 splicing mutations are new targetable oncogenic drivers reported in 3% of non-small cell lung cancer (NSCLC) cases and have been shown to be more…”
Get full text

Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer by Rodier, Thomas, Puszkiel, Alicja, Cardoso, Evelina, Balakirouchenane, David, Narjoz, Céline, Arrondeau, Jennifer, Fallet, Vincent, Khoudour, Nihel, Guidi, Monia, Vidal, Michel, Declèves, Xavier, Csajka, Chantal, Alexandre, Jérôme, Cadranel, Jacques, Fabre, Elizabeth, Wislez, Marie, Goldwasser, François, Blanchet, Benoit

“…High interindividual variability (IIV) of the clinical response to epidermal growth factor receptor (EGFR) inhibitors such as osimertinib in non-small-cell…”
Get full text

Prospective screening for ALK : Clinical features and outcome according to ALK status by Fallet, Vincent, Cadranel, Jacques, Doubre, Hélène, Toper, Cécile, Monnet, Isabelle, Chinet, Thierry, Oliviero, Gérard, Foulon, Guillaume, De Cremoux, Hubert, Vieira, Thibault, Antoine, Martine, Wislez, Marie

“…Abstract The aim of this study was to analyse the clinico-pathological characteristics and outcomes of a cohort of French patients who were prospectively…”
Get full text

Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells by Gazzano, Marianne, Parizot, Christophe, Psimaras, Dimitri, Vozy, Aurore, Baron, Marine, Abbar, Baptiste, Fallet, Vincent, Litvinova, Elena, Canellas, Anthony, Birzu, Cristina, Pourcher, Valérie, Touat, Mehdi, Weiss, Nicolas, Demeret, Sophie, Roos-Weil, Damien, Spano, Jean-Philippe, Lebbe, Celeste, Salem, Joe-Elie, Cadranel, Jacques, Hervier, Baptiste, Gorochov, Guy, Guihot, Amélie

“…Immune checkpoint inhibitors (ICI) widely improved the treatment of solid and hematologic malignancies. Yet, a remarkable proportion of patients receiving ICI…”
Get full text

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer by Costantini, Adrien, Corny, Jennifer, Fallet, Vincent, Renet, Sophie, Friard, Sylvie, Chouaid, Christos, Duchemann, Boris, Giroux-Leprieur, Etienne, Taillade, Laurent, Doucet, Ludovic, Nguenang, Marina, Jouveshomme, Stéphane, Wislez, Marie, Tredaniel, Jean, Cadranel, Jacques

“…Nivolumab for the treatment of advanced nonsmall cell lung cancer (NSCLC) evaluated in phase III trials showed 50% progression at first evaluation, but better…”
Get full text

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience by Cornelis, François H., Ben Ammar, Mohamed, Nouri-Neuville, Maud, Matton, Lise, Benderra, Marc Antoine, Gligorov, Joseph, Fallet, Vincent, Mir, Luis M.

Get full text

Secondary resistance to erlotinib: acquired T790M mutation and small-cell lung cancer transformation in the same patient by Fallet, Vincent, Ruppert, Anne-Marie, Poulot, Virginie, Lacave, Roger, Belmont, Laure, Antoine, Martine, Cadranel, Jacques, Wislez, Marie, Lavolé, Armelle

Get more information

Emerging cancer risks in BRCA2 pathogenic germline variant carriers by Benusiglio, Patrick R, Dardenne, Antoine, Fallet, Vincent, Cadranel, Jacques

Get full text

Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer? by Fallet, Vincent, Sanchis-Borja, Mateo, Benusiglio, Patrick R, Cadranel, Jacques

Get full text

Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report by Wang, Pascal, Matton, Lise, Kebir, Fatima, Kerrou, Khaldoun, Dubois, Antonin, Lacave, Roger, Cadranel, Jacques, Fallet, Vincent

“…What is already known about this subject?•Rearranged during transfection (RET) gene fusion are unfrequent (1%-2%) but validated as target mutations in…”
Get full text

Multimodal machine learning model prediction of “individual” response to immunotherapy in 1L stage IV NSCLC by Cadranel, Jacques, Sebane, Louise, Ferrer, Loïc, Canellas, Anthony, Etchepare, Guillaume, Meteye, Constance, Gallinato, Olivier, Fallet, Vincent, Lacave, Roger, Menu, Philippe, Colin, Thierry

“…e21151 Background: Immunotherapy (IO) is the standard of care in 1L stage IV non-small cell lung cancer (NSCLC) cases that are not eligible for targeted…”
Get full text

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study by Marquette, Charles-Hugo, Boutros, Jacques, Benzaquen, Jonathan, Ferreira, Marion, Pastre, Jean, Pison, Christophe, Padovani, Bernard, Bettayeb, Faiza, Fallet, Vincent, Guibert, Nicolas, Basille, Damien, Ilie, Marius, Hofman, Véronique, Hofman, Paul, MARQUETTE, Charles-Hugo, BOUTROS, Jacques, Benzaquen, Jonathan, FERREIRA, Marion, PASTRE, Jean, Pison, Christophe, PADOVANI, Bernard, BETTAYEB, Faiza, FALLET, Vincent, GUIBERT, Nicolas, BASILLE, Damien, ILIE, Marius, HOFMAN, Véronique, HOFMAN, Paul, ISRAEL-BIET, Dominique, CHABOT, François, GUILLAUMOT, Anne, DESLEE, Gaetan, PEROTIN, Jeanne-Marie, DURY, Sandra, MAL, Hervé, MARCEAU, Armelle, Kessler, Romain, Vergnon, Jean-Michel, Pelissier, Carole, Di Palma, Fabrice, Cuvelier, Antoine, PATOUT, Maxime, Bourdin, Arnaud, GAMEZ, Anne Sophie, ANDREJAK, Claire, POULET, Claire, FRANCOIS, Géraldine, Jounieaux, Vincent, Roche, Nicolas, Jouneau, Stéphane, Brinchault, Graziella, Bonniaud, Philippe, ZOUAK, Ayoub, Scherpereel, Arnaud, BALDACCI, Simon, CORTOT, Alexis, Mornex, Jean François, Steenhouwer, François, LEROY, Sylvie, BERTHET, Jean-Philippe, FONTAS, Eric, BULSEI, Julie, CRUZEL, Coralie, Pradelli, Johanna, Fontaine, Maureen, MANIEL, Charlotte, Griffonnet, Jennifer, BUTORI, Catherine, SELVA, Eric, POUDENX, Michel, AguilanIu, Bernard, Ferretti, Gilbert, Arbib, François, Briault, Amandine, Toffart, Anne-Claire, Dahalani, Raissa, Destors, Marie, Chanez, Pascal, GREILLIER, Laurent, ASTOUL, Philippe, BARLESI, Fabrice, GAUBERT, Jean-Yves, Mazières, Julien, Marchand-Adam, Sylvain, Cadranel, Jacques, CHAABANE, Nouha, IZADIFAR, Armine, ROSENCHER, Lise, RUPPERT, Anne-Marie, VIEIRA, Thibault, MATHIOT, Nathalie

“…Lung cancer screening with low-dose chest CT (LDCT) reduces the mortality of eligible individuals. Blood signatures might act as a standalone screening tool,…”
Get full text

Invited editorial: Q and A on hereditary lung cancer by Benusiglio, Patrick R., Fallet, Vincent, Cadranel, Jacques

“…Advances in the field of genetic susceptibility to respiratory diseases (e.g. pulmonary fibrosis, emphysema, cystic fibrosis, pulmonary hypertension) have led…”
Get full text